A new drug substance found fail to meet specification for
an unknown Impurity during stability study(Specific
change),how would further proceed?
Answer Posted / vikas kumar
Firstly it was not clear on which condition we are getting
the OOS and at which time point.
It it was failed in Accelerated condition than we have to
look definately for intermediate condition for 12M.
if it was in long term condition than we have to firstly
raise the OOS and and proceed as per OOS procedure similary
we can check wether the method was stability indicating or
not.
| Is This Answer Correct ? | 4 Yes | 1 No |
Post New Answer View All Answers
How to set analytical specification for combination products?
In rs method development when we are going area normalization method to dilute standard method?
how to qualify the impurity?
how a particular wavelength can be different for a particular compund while analysing by uv and by HPLC.
Why sodium hydroxide used for maintain pH of phosphate buffer
if you have given a blank water how you analyse by general analytical techniques?
what is the origin to prepare standard operating procedure
in monograph 7 imp are there but in vendor showing 5 imp do not req to include 2 imp for that what will be justification?
which batch require to use for analytical method validation?
inhouse product is in capsule form in combination and RLD is in tablet form then can we proceed for multimedia CDP? in inhouse capsule product disso is paddle with sinker in release media is there then RLD product in tablet form then with same as paddle with sinker we can proceed n.a.?
what is the disso medium for tropsiun chloride
What is the difference between spectro meter and spectro photo meter?
pharma industries oriented
What is viod volume and peak purity in HPLC?
What is the formula for relative diffrence for standard solution in solution stability in validation?